Diabetes is the leading cause of kidney failure, and scientists have found that infusing just a small dose of a cytokine, thought to help cause that failure, can instead prevent or reverse it.
The cytokine IL-17A has long been considered a classic promoter of inflammation, which plays a major role in progression of diabetes-related kidney disease, or diabetic nephropathy, said Dr. Ganesan Ramesh, kidney pathologist at the Vascular Biology Center at the Medical College of Georgia at Augusta University.
His lab was pursuing its role in kidney damage but found that when they deleted the IL-17 gene in mice, then induced diabetes, it resulted in increased kidney injury, Ramesh said. They looked next at patients with severe diabetic nephropathy, and found levels of IL-17A reduced in their blood and urine.
In follow-up studies in animal models of both type 1 and type 2 diabetes, IL-17A’s surprising role grew: When researchers infused a small amount of IL-17A every 48 hours for several weeks, it prevented or reversed diabetic nephropathy in their diabetes models. In fact, the therapy worked best in late-stage diabetic nephropathy, Ramesh said. IL-17A therapy also reduced high levels of fat in the blood, a hallmark of type 2 diabetes that is believed to contribute to related kidney and cardiovascular problems.
“It clearly indicates that IL-17A is protective,” Ramesh said. “It does well for the kidney in suppressing damage in response to diabetes.” Ramesh is corresponding author of the study, published in the Journal of the American Society of Nephrology, which is the first to look at IL-17’s role in chronic kidney disease.
IL-17A seems to protect kidney cells multiple ways, including inducing the anti-inflammatory molecule AMWAP, or activated microglia/macrophage WAP domain protein. The cytokine also appeared to aid survival and regeneration of key kidney cells, including podocytes and epithelial cells in the tubules. Podocytes help the kidney retain important large molecules such as protein, and epithelial cells line tubules where these essentials are reabsorbed.
To date, the MCG research team has seen no ill effects from overexpressing IL-17A in mice kidneys and to some extent in their circulation. Currently, there are no drugs available to increase patients’ IL-17A levels, but there are inhibitors for the cytokine that is considered causative in autoimmune diseases such as Crohn’s. Emerging laboratory and clinical trial data indicate there may need to be drugs that do both.
As examples, in a clinical trial of an antibody for IL-17A in patients with Crohn’s, the drug did not seem to help patients, and, in fact, some patients reported worsening symptoms. However, the National Psoriasis Foundation reports good experience with the use of biologics that block 1L-17 for the skin disorder. Meanwhile, French researchers have shown that giving IL-17A to mice suppressed the development of atherosclerosis, while a deficiency in the cytokine gene accelerated development of the arterial disease associated with inflammation.
The MCG researchers note that whether IL-17 promotes or suppresses inflammation may be related to the level and length of time it’s stimulated. Response may also depend on which of the six different forms of IL-17 is activated, the receptors activated and resulting downstream signaling. In their studies, for example, increasing IL-17C and IL-17E levels did not have the same positive effect on diabetic nephropathy as IL-17A as well as IL-17F.
In follow up to the therapy’s particular success with advanced disease, next steps include examining its impact on essentially destroyed kidneys. “If you can recover function from the dead kidney, you could save millions of people from a lifetime of dialysis,” Ramesh said.
Read more: Scientists prevent, reverse diabetes-related kidney destruction in animal model
The Latest on: Diabetes-related kidney destruction
[google_news title=”” keyword=”diabetes-related kidney destruction” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diabetes-related kidney destruction
- Study identifies strong link between red, processed meat intake and severe kidney damage in diabetic womenon May 8, 2024 at 5:17 am
The link between red, processed, and white meat consumption and the likelihood of developing kidney damage and diabetic nephropathy.
- Ozempic or Buston May 7, 2024 at 5:00 pm
She has type 2 diabetes, chronic kidney disease, and a host of other health concerns ... For 40 years, we’ve tried to curb the spread of obesity and its related ailments, and for 40 years, we’ve ...
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcripton May 6, 2024 at 7:05 am
May 5, 2024 Lexicon Pharmaceuticals, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to ...
- Kidney disease: How to protect yourself and the symptoms the NHS may not spoton April 29, 2024 at 5:00 am
The rising rates of chronic kidney problems are thought to reflect the soaring numbers of people with Type 2 diabetes and hypertension, while chronic kidney damage can also be induced by genetic ...
- What Causes Low Blood Sugar Without Diabetes?on April 28, 2024 at 5:00 pm
This may be related to issues with your: metabolism hormone levels organs (kidneys, liver, or pancreas) Hypoglycemia in people without diabetes is less common than hypoglycemia which occurs in ...
- Type 1 Diabeteson April 18, 2024 at 5:00 pm
Kidney damage. About 20%-30% of people with type 1 diabetes get a condition called nephropathy. The chance of getting it goes up over time. It’s most likely to show up 15-25 years after the ...
- DJ Mister Cee's Cause of Death Revealed as Diabetes-Related Coronary Artery/Kidney Diseaseon April 16, 2024 at 1:40 pm
According to a statement provided by the family to AllHipHop, the DJ's cause of death was "diabetes related coronary artery/kidney disease." "On behalf of the Lebrun, Wilson, Calixte families we ...
- How to control and manage type 2 diabetes with and without medicationon April 11, 2024 at 5:00 pm
This increases the likelihood of a person developing complications of diabetes, such as kidney disease and nerve damage. Learn more about how smoking affects diabetes. Research from 2019 suggests ...
- Age-related Associations of Hypertension and Diabetes Mellitus with Chronic Kidney Diseaseon April 10, 2024 at 5:00 pm
The age-specific prevalence of stage 3 or 4 CKD at 20 to 49, 50 to 69 and ≥70 years of age was 1.5%, 11.7%, and 39.0%, respectively, among individuals with diagnosed or undiagnosed diabetes ...
- Diabetes Dilemmaon November 10, 2023 at 4:44 am
Watch the video below: One common thread was that most people knew diabetes revolved around something related to blood sugar ... including cardiovascular diseases, kidney damage, nerve damage ...
via Bing News